Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

In patients with catheter-associated asymptomatic bacteriuria caused by multidrug-resistant Pseudomonas, antibiotic treatment ...

NOSO-502 has demonstrated antibacterial activity against multidrug-resistant clinical isolates ... intended for the treatment ofsystemic Pseudomonas aeruginosa infections and Candida infections.

Antibiotics with novel mechanisms of action are needed to combat the growing health threat from pathogenic bacteria that are resistant to ... high specificity for Pseudomonas aeruginosa ...

Pseudomonas aeruginosa bacteria are multidrug-resistant (MDR), including the common antibiotic, carbapenems. Pseudomonas aeruginosa infections carry specific risks in immunocompromised patients.

Pseudomonas aeruginosa is included in the World Health Organization’s Bacterial Priority Pathogen List 2024 because of its concerning ability to acquire and develop high levels of antimicrobial ...

New research from Tulane University has identified a unique genetic signature in bacteria that can predict their likelihood of developing antibiotic resistance, a finding that can help quickly ...

More information: Eleri A. Ashworth et al, Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo, Nature Communications (2024). DOI: 10. ...

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World Health Organization ...

If not, the bacteria could become more resistant and harder to treat. Simple cases of Pseudomonas aeruginosa can start improving within a few days, while more severe infections may take weeks or ...

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...